The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
April 18th 2024
Meta-analysis of 11 phase 3 trials shows SGLT2 inhibitors reduce cardiovascular event risk by 9% across diverse patient populations.
Medical Crossfire®: Updates in Continuous Glucose Monitoring—Having the Important Conversations With Your Patients
View More
Evaluating the Recent Advancements in Chronic Kidney Disease Treatment: A Case-Based Approach to Managing CKD and Related Comorbidities
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Torsemide Provides No Benefit Over Furosemide for Mortality, Hospitalization in Heart Failure
November 5th 2022Results of the TRANSFORM-HF trial presented at AHA 22 indicate there were no significant differences in rate of all-cause mortality or hospitalization with the use of torsemide compared with furosemide in people with heart failure.
Long, Irregular Menstrual Cycles Could Signal Increased Cardiovascular Risk Later in Life
October 25th 2022An analysis of data from Nurses' Health Study II participants suggests long or irregular menstrual cycles were associated with an increased risk of incident cardiovascular disease later in life.
Patients with HIV and NAFLD at an Increased Risk of Cardiovascular Disease
Patients with NAFLD were more likely to have comorbidities, including diabetes, hypertension, chronic respiratory disease, hypothyroidism, chronic kidney disease, sleep apnea, and hyperlipidemia.
American Heart Association Announces Creation of Cardiogenic Shock Registry
October 20th 2022Announced on October 19, the American Heart Association's Cardiogenic Shock Registry powered by Get With The Guidelines was created with the intent of providing researchers with access to real-time data related to care and outcomes of patients with cardiogenic shock in the US to help improve management.
FDA Approves Medtronic Cardiac Lead for Conduction System Pacing
October 17th 2022Announced on October 17, the US FDA's expanded indication for Medtronic's SelectSecure™ MRI SureScan Model 3830 cardiac lead makes it the first and only device with FDA approval for conduction system pacing, according to a release from Medtronic.